Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the role of postoperative radiotherapy in patients with IIIA(N2) non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC [Phase 2]
Phase 2 trial update exploring camrelizumab with chemotherapy in adults with medically inoperable early stage non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum [Phase 3]
Phase 3 trial evaluating GTx-024 for muscle wasting in first-line platinum-treated non-small cell lung cancer patients has completed with re…
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy [Phase 2]
Phase 2 trial evaluating enzastaurin versus placebo for brain metastases from lung cancer after whole-brain radiation therapy has completed …
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial [Phase 3]
Phase 3 clinical trial update for an elderly patient individualized chemotherapy approach in stage IV non-small cell lung cancer; current st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC [Phase 2]
Phase II study evaluating sintilimab as second-line therapy for biomarker-selected advanced or metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy [Phase 2]
Phase 2 trial evaluating toripalimab as maintenance therapy after first-line chemotherapy in driver-gene negative advanced non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC [Phase 4]
A Phase 4 clinical trial evaluating rh-endostatin with concurrent chemoradiotherapy followed by durvalumab maintenance in non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial comparing microwave ablation plus camrelizumab versus camrelizumab alone in metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer [Phase 3]
Phase 3 trial comparing tivantinib plus erlotinib vs placebo plus erlotinib in non-squamous non-small-cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2020-10-29Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) [Phase 2, Phase 3]
Phase 2/3 clinical trial update on BCD-100 as second-line monotherapy for non-small cell lung cancer, detailing efficacy, safety, and pharma…
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy [Phase 2]
Phase 2 trial investigating depletion of myeloid-derived suppressor cells to enhance anti-PD-1 therapy in non-small cell lung cancer (Stage …
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating atezolizumab with carboplatin-paclitaxel with/without bevacizumab vs carboplatin-paclitaxel-bevacizumab in stage IV…
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 multicenter, open-label study of the EGFR-mutant TKI EGF816 in adult patients with EGFR-mutant solid malignancies, including advan…
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) [Phase 2]
Phase 2 imaging trial evaluating [68Ga]-NeoBOMB1 for GRPR-expressing tumors has terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label [Phase 2]
A Phase 2 trial evaluating ficlatuzumab plus erlotinib versus placebo plus erlotinib in previously untreated metastatic EGFR-mutated non-sma…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial exploring proton beam radiation with concurrent chemotherapy and nelfinavir for inoperable stage III non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC [Phase 2]
Phase 2 trial updating nivolumab in combination with chemotherapy or with ipilimumab for advanced EGFR-mutant or ALK-rearranged non-small ce…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating nivolumab plus metformin for stage III-IV non-small cell lung cancer unsuitable for surgery; status unknown with re…
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II Trial [Phase 2]
Phase II trial evaluating almonertinib as upfront treatment for uncommon EGFR mutation–harboring non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) [Phase 3]
Phase 3 trial (IMpower 132) evaluating atezolizumab with chemotherapy (carboplatin or cisplatin + pemetrexed) versus chemotherapy alone in c…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Single Arm on the Tolerability of Weekly Nab-paclitaxel [Phase 2]
Phase 2 single-arm study evaluating tolerability of weekly nab-paclitaxel in NSCLC completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating oncolytic MG1-MAGEA3 with Ad-MAGEA3 vaccine in combination with pembrolizumab for non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033) [Phase 3]
A Phase 3 clinical trial comparing pembrolizumab to docetaxel in previously treated non-small cell lung cancer has completed and results hav…
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing Polyglutamate Paclitaxel with gemcitabine or vinorelbine in advanced or recurrent non-small cell lung cancer was t…